Pharmacological characterization of B-HT 933 (2-amino-6-ethyl-4,5,7,8-tetrahydro-6H-oxazolo-[5,4-d]-azepindihydrochloride) as a hypotensive agent of the ?Clonidine-type?
- 1 January 1977
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 300 (1), 39-46
- https://doi.org/10.1007/bf00505078
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Studies on the centrally mediated hypotensive activity of guanabenzEuropean Journal of Pharmacology, 1976
- The central modulatory effect of clonidine on the cardiodepressor reflex after suppression of synthesis and storage of noradrenalineEuropean Journal of Pharmacology, 1975
- Facilitation of vagal reflex bradycardia by an action of clonidine on central α-receptorsEuropean Journal of Pharmacology, 1972
- Evidence for a central activation of a vagal cardiodepressor reflex by clonidineEuropean Journal of Pharmacology, 1972
- ?-Sympathicomimetische Eigenschaften als Ursache der blutdrucksteigernden und blutdrucksenkenden Wirkung von BAY 1470 (2-(2,6-Xylidino)-5,6-dihydro-4H-1,3-thiazinhydrochlorid)Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1971
- Evidence for a central noradrenaline receptor stimulation by clonidineLife Sciences, 1970
- Localization of the hypotensive effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, catapresan)European Journal of Pharmacology, 1969
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 115)European Journal of Pharmacology, 1968
- Adrenergic Neurone Blocking AgentsAnnual Review of Pharmacology, 1965
- Technik und Anwendung der Kälteverdünnungsmethode zur Diagnostik von HerzfehlernKlinische Wochenschrift, 1962